KCM
THC icon

Khrom Capital Management’s Tenet Healthcare THC Stock Holding History

Khrom Capital Management’s Portfolio THC Stock Details THC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$45.7M Buy
+244,118
New +$44.9M 3.83% 10
2026
Q1 		– Sell
-504,279
Closed -$100M – 18
2025
Q4 		$100M Hold
504,279
– – 10.42% 4
2025
Q3 		$102M Sell
504,279
-50,643
-9% -$8.99M 10.64% 4
2025
Q2 		$97.7M Buy
554,922
+83,700
+18% +$12.6M 10.88% 4
2025
Q1 		$63.4M Buy
471,222
+200,999
+74% +$26.5M 8.47% 5
2024
Q4 		$34.1M Hold
270,223
– – 3.86% 11
2024
Q3 		$44.9M Hold
270,223
– – 5.7% 10
2024
Q2 		$35.9M Sell
270,223
-53,295
-16% -$6.42M 6.79% 7
2024
Q1 		$34M Sell
323,518
-100,500
-24% -$9.03M 8.09% 6
2023
Q4 		$32M Buy
424,018
+173,903
+70% +$11M 10.06% 5
2023
Q3 		$16.5M Buy
250,115
+8,173
+3% +$611K 7.95% 7
2023
Q2 		$19.7M Sell
241,942
-130,472
-35% -$9.29M 10.68% 4
2023
Q1 		$22.1M Buy
372,414
+1,823
+0.5% +$101K 17.08% 1
2022
Q4 		$18.1M Buy
370,591
+100,367
+37% +$4.64M 17.28% 2
2022
Q3 		$13.9M Buy
270,224
+181,064
+203% +$10.7M 12.65% 3
2022
Q2 		$4.69M Buy
+89,160
New +$6.2M 4.66% 8

Other funds holding THC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Khrom Capital Management's THC Position: Q2 2026 in Review

Khrom Capital Management opened a new position in Tenet Healthcare (THC) in Q2 2026: 244,118 shares worth $45.7M. The stake represents 3.83% of the portfolio and ranks #10 among its holdings. This is a return to the name: Khrom Capital Management previously reported a position in THC as recently as Q4 2025.

Khrom Capital Management first reported a position in THC in Q2 2022 and has held it in 16 quarters since. The position peaked at $102M in Q3 2025. 681 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Khrom Capital Management held 244,118 shares of Tenet Healthcare worth $45.7M as of Q2 2026.
  • Tenet Healthcare was a new Khrom Capital Management position in Q2 2026.
  • Tenet Healthcare made up 3.83% of Khrom Capital Management's portfolio in Q2 2026, its #10 holding.
  • Khrom Capital Management first reported a position in Tenet Healthcare in Q2 2022 and has held it in 16 quarters since.
  • Khrom Capital Management's Tenet Healthcare position peaked at $102M in Q3 2025.
  • 681 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Khrom Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.